Lobo, J.; Cardoso, A.R.; Miranda-Gonçalves, V.; Looijenga, L.H.J.; Lopez, M.; Arimondo, P.B.; Henrique, R.; Jerónimo, C.
Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics 2021, 13, 73.
https://doi.org/10.3390/pharmaceutics13010073
AMA Style
Lobo J, Cardoso AR, Miranda-Gonçalves V, Looijenga LHJ, Lopez M, Arimondo PB, Henrique R, Jerónimo C.
Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics. 2021; 13(1):73.
https://doi.org/10.3390/pharmaceutics13010073
Chicago/Turabian Style
Lobo, João, Ana Rita Cardoso, Vera Miranda-Gonçalves, Leendert H. J. Looijenga, Marie Lopez, Paola B. Arimondo, Rui Henrique, and Carmen Jerónimo.
2021. "Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest" Pharmaceutics 13, no. 1: 73.
https://doi.org/10.3390/pharmaceutics13010073
APA Style
Lobo, J., Cardoso, A. R., Miranda-Gonçalves, V., Looijenga, L. H. J., Lopez, M., Arimondo, P. B., Henrique, R., & Jerónimo, C.
(2021). Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics, 13(1), 73.
https://doi.org/10.3390/pharmaceutics13010073